Provided by Tiger Fintech (Singapore) Pte. Ltd.

Collegium Pharmaceutical

27.65
+0.59002.18%
Post-market: 27.650.00000.00%16:05 EDT
Volume:185.30K
Turnover:5.09M
Market Cap:888.44M
PE:14.89
High:28.19
Open:27.41
Low:27.01
Close:27.06
Loading ...

Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus

Simply Wall St.
·
25 Dec 2024

Improved Revenues Required Before Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Find Their Feet

Simply Wall St.
·
24 Dec 2024

Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest

Simply Wall St.
·
14 Nov 2024

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?

Zacks
·
13 Nov 2024

Collegium to Participate in Upcoming Investor Conferences

GlobeNewswire
·
12 Nov 2024

Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
09 Nov 2024

Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

GuruFocus.com
·
08 Nov 2024

Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock?

Zacks
·
08 Nov 2024

Collegium Pharmaceutical: Hold Rating Amid Uncertainty Despite Strong Q3 Performance

TIPRANKS
·
08 Nov 2024

Collegium Pharmaceutical Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
08 Nov 2024

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings

Zacks
·
08 Nov 2024

Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates

Zacks
·
08 Nov 2024

Collegium Pharmaceutical Taps Vikram Karnani as CEO

Dow Jones
·
08 Nov 2024

Collegium Pharmaceutical Q3 Adj $1.61 Beats $1.59 Estimate, Sales $159.30M Beat $155.57M Estimate

Benzinga
·
08 Nov 2024

BRIEF-Collegium Pharmaceutical Q3 Revenue USD 159.3 Million Vs. IBES Estimate USD 155.6 Million

Reuters
·
08 Nov 2024

Collegium Pharmaceutical Inc -Reaffirms Its Full-Year 2024 Guidance

THOMSON REUTERS
·
08 Nov 2024

Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy?

Zacks
·
06 Nov 2024